Domain-Specific Statistics: Why Your Field’s Methods Matter

Domain-specific statistics is the set of methods, conventions and reporting rules that a particular field has settled on because its data have particular problems: clustered patients, repeated measures, censored survival times, thousands of correlated features. A t-test is a t-test everywhere. Whether a t-test is the right test, and what you must report beside it, depends on your discipline.

This guide explains what “domain-specific” means in practice, shows where generic defaults go wrong, and describes how research groups can make field methods repeatable rather than dependent on one person’s memory.

TL;DR

• Domain-specific statistics means methods and conventions tied to the structure of a field’s data, such as intracluster correlation in cluster trials or multiplicity in omics.
• General-purpose software defaults often assume independent observations and complete data. Many real research datasets violate both.
• A written statistical analysis plan (SAP) is the strongest protection: it fixes populations, missing-data handling and multiplicity control before anyone sees outcomes.
• Tools can encode your field’s rules so they are applied the same way every time, but a human must still approve the method.
• PlotStudio AI adds an agentic analytics layer on top of R, Python, Stata, SPSS, SAS and Jupyter. It plans, runs, inspects and documents analyses with reviewable methods.

Table of Contents

• What “domain-specific” means in statistics
• Where generic defaults fail
• A quick comparison: generic versus domain-aware analysis
• The statistical analysis plan is where domain knowledge lives
• How to apply your field’s methods without a statistician on call
• Where PlotStudio AI fits in the research toolkit
• Our perspective
• Trying it on your own data
• FAQ
• Sources

What “domain-specific” means in statistics

The phrase gets used in two ways, and the search results for it mix them up. In machine learning, “domain” often means a data distribution, and “domain generalization” is about models that fail when test data come from a different source. That is a different topic.

Here we mean the research sense: the statistical toolkit of a discipline. Epidemiology leans on survival models and confounder control. Clinical trials have estimands, analysis populations and multiplicity rules. Psychology works with scales, measurement models and effect sizes. Economics works with panel data and clustered standard errors. Engineering simulation studies care about replication across random seeds and parameter sweeps.

Three things make a method domain-specific:

1. The data structure. Patients nested in clinics, measurements nested in participants, genes measured by the thousand.
2. The inferential question. A regulator, a journal or a thesis committee wants a specific quantity estimated, not just a p-value.
3. The reporting convention. Which diagnostics, which adjustment, which sensitivity analyses, in what order.

A statistician who has worked in your field carries these in their head. That is exactly why they are fragile when a PhD student is alone with a dataset and a deadline.

Where generic defaults fail

General statistical routines are built for the common case: independent observations, roughly complete data, one pre-specified comparison. Real research data break these assumptions in predictable, field-specific ways.

Clustered data in trials

In a cluster randomized trial, people from the same clinic or village resemble each other. The intracluster correlation coefficient measures that resemblance, and it inflates the sample size you need through the design effect. Analyze such data as if every participant were independent and your standard errors are too small, so your confidence intervals look better than the evidence supports. A published SAP template makes the same point: certain trial types have recurring statistical characteristics, and it recommends engaging biostatisticians with experience in that domain.

Missing data and intercurrent events

In clinical research, “missing” is not one thing. The ICH E9(R1) addendum on estimands and sensitivity analysis distinguishes events such as treatment switching or death, which affect how the clinical question is defined, from data that were simply not collected. Dropping incomplete rows is a default in many tools. In a trial it can change the question you are answering.

High-dimensional and longitudinal data

Omics studies measure thousands of features, often repeatedly over time. A recent review of longitudinal omics analysis surveys the statistical and computational approaches built for this setting. Running thousands of uncorrected tests, or ignoring within-subject correlation, produces results that look significant and do not replicate.

Psychology and the cost of defaults

Even the “safe” choice is not universal. Methodological work in Psychological Methods examines when a nonregularized, hypothesis-testing approach to network estimation can be preferable to a regularized one, with attention to controlling false positives. The lesson is not that one method wins. It is that tool defaults encode an assumption, and your field may have a reasoned alternative.

Survival and time-to-event outcomes

Clinical and epidemiological studies routinely have censored outcomes. Treating follow-up time as an ordinary continuous variable discards the censoring information. Kaplan-Meier estimates, log-rank tests and Cox proportional hazards models exist for this reason, and the Cox model comes with its own assumption (proportional hazards) that must be checked and reported.

A quick comparison: generic versus domain-aware analysis

The statistical analysis plan is where domain knowledge lives

If you take one habit from this article, make it the SAP. The SAP template cited above describes it as foundational to reproducibility: statistical hypotheses, variable definitions and analysis populations are specified prospectively, before data unblinding, to limit bias. It should also cover multiplicity, sensitivity analyses and missing data, and the rules for including participants in each analysis population.

A useful test is whether several independent statisticians, given only the analysis dataset and the plan, would produce the same results. That is a high bar, and it is the right one. It is also the same bar a supervisor applies when they ask why they cannot reproduce your numbers.

The discipline extends to surprises. A perspective on planning statistical analyses in nutrition trials describes finalizing the plan before database lock and unblinding, and documenting unexpected patterns transparently rather than folding them into the primary analysis after the fact.

Outside trials, you may not call it an SAP, but the logic carries over. A thesis chapter, a reviewer response and a lab’s standard workflow all benefit from a written statement of methods, assumptions and exclusions made before you look at results. A guide on bridging clinical investigators and statisticians notes that the study design, sample size and analysis must be able to evaluate the research hypothesis, or the consequences can be serious. Our own notes on research reproducibility cover the practical side.

How to apply your field’s methods without a statistician on call

Not every PhD student has a biostatistician down the hall. Here is a workable routine.

1. Write down the estimand or question first. What quantity, in which population, compared with what?
2. List the data-structure hazards. Clustering, repeated measures, censoring, missingness, multiplicity. Each one maps to a family of methods.
3. Find your field’s reporting guidance. Journal checklists, trial reporting standards and your group’s own past papers are good starting points.
4. Specify the plan before the outcome analysis. Include exclusions, covariates, the multiplicity approach and sensitivity analyses.
5. Run it as code. Scripts and notebooks let a supervisor rerun the analysis.
6. Record deviations. If you change course, say when and why.
7. Get a statistician to review the plan. Even one hour on the plan is worth more than a week of fixing results.

If you work with patient data, add one more step: confirm with your institution’s information governance team where the data may be processed before you choose any tool. Rules differ by country and by dataset, so that decision belongs to your data protection officer and ethics approval, not to a software vendor.

Where PlotStudio AI fits in the research toolkit

R, Python, Stata, SPSS, SAS and Jupyter are the statistical computing foundation, and PlotStudio AI does not replace any of them. Those tools compute. What they do not do is plan a multi-step investigation, check intermediate output, and write down what happened.

PlotStudio AI is agentic analytics for researchers. You connect tabular data and define an objective. Specialized agents plan the investigation, write and run real code, inspect intermediate results and synthesize the findings. We think of it as an emerging must-have layer in the modern research toolkit: the layer that plans, executes, inspects, validates and documents a complete analysis, sitting beside the tools you already trust.

Three features matter specifically for domain-specific work:

• Plan Mode. You review and modify the proposed approach before anything runs, including methods, assumptions and the steps the agent intends to take. That is where you catch a default that does not suit your design, such as an independence assumption on clustered data.
• Skills. Skills encode how a lab, group or discipline approaches analysis: required procedures, statistical conventions, methodological constraints and reporting expectations. A group can write its conventions down once and have them applied consistently.
• Reproducible outputs. Completed work is preserved as searchable Analysis Pages and can be exported as notebooks and PDF reports, so a collaborator or supervisor can see the code, statistics and charts behind each number.

The platform supports Python and R workflows and is designed for methods researchers use regularly: regression, ANOVA, mixed-effects models, survival analysis, Cox proportional hazards models and multiple-comparison procedures. Analyses can run locally on your machine, which suits privacy-sensitive work where datasets should not be uploaded to conventional cloud analytics platforms.

A caution we repeat to every researcher: an AI agent does not make a method correct. It makes the method visible and repeatable. You remain responsible for choosing it, and your statistician remains the right person to challenge it.

Our perspective

We built PlotStudio AI around a simple observation: the hard part of research analysis is rarely running a test. It is remembering, under pressure, which test your field expects, what assumptions it carries, and how to show a reviewer you checked.

One-shot answers are weak at this. A chat reply that produces a chart tells you little about whether the data were clustered, whether missingness was examined, or whether a multiple-comparison procedure was applied. So we focus on the workflow: a plan you can read and edit, code that actually runs, intermediate results the agent inspects, and a record you can hand to a supervisor.

We also think of domain knowledge as something a group should own. A lab’s conventions on exclusions, covariates and reporting should not live in one postdoc’s head and leave when they do. Skills are our attempt to make those conventions explicit and reusable, without pretending they can substitute for training.

If you take one thing from us: write the plan first, whoever or whatever executes it.

— Aymen

Trying it on your own data

The quickest way to judge whether this approach suits your field is to run a past analysis you already trust and compare the plan, code and results. PlotStudio AI has a free trial with no published price; see the pricing page for details.

Paid options as published: Managed Credits at 69.99 USD per month, and Bring Your Own Key at 39.99 USD per month. Bring Your Own Key is also listed on the academic page at 399.90 USD per year. Groups that want a managed deployment can look at the enterprise page, which lists a one-off pilot fee of 500 USD.

For more on choosing tools, see our guides to scientific data analysis software and research data analysis tools.

FAQ

What is the difference between domain-specific statistics and general statistics?

General statistics covers methods that apply broadly, such as descriptive summaries, t-tests and linear regression. Domain-specific statistics adds the methods, assumptions and reporting rules that a field needs because of its data, such as cluster-trial analysis in medicine or panel-data models in economics. In practice the two overlap, and the domain determines which general tool is appropriate.

Do I need a biostatistician if I use an AI analysis tool?

For clinical or trial research, yes, ideally at the planning stage. Published guidance on SAPs recommends engaging biostatisticians with domain experience, because specialized issues are easy for generalists to miss. A tool can apply and document a plan consistently, but it does not replace expert review of the design.

Is domain-specific statistics the same as domain generalization in machine learning?

No. Domain generalization is about training models that perform on data from distributions they were not trained on. Domain-specific statistics is about using the methods and conventions that fit a research field’s data and questions. The terms share a word and little else.

How can a research group keep analysis methods consistent across students?

Write the conventions down: exclusions, covariates, multiplicity approach, diagnostics and reporting format. Keep analyses as code, and review the plan before the results. In PlotStudio AI, Skills are designed to encode those conventions so the agent follows them, and Plan Mode lets you check the approach before it runs.

Sources

• A template for the authoring of statistical analysis plans
• Perspective: Planning and Conducting Statistical Analyses for Human Nutrition Randomized Controlled Trials
• Bridging Clinical Investigators and Statisticians: Writing the Statistical Methodology for a Research Proposal
• ICH E9 (R1) addendum on estimands and sensitivity analysis in clinical trials
• Longitudinal omics data analysis: approaches and applications
• Psychological Methods manuscript on nonregularized network estimation
• Cluster Randomized Trials and the Intracluster Correlation Coefficient

Recommended

• Statistical Analysis Methodology Articles
• Advanced Statistical Methods a Practical Guide for 2026
• How to Write Methods Section for Rigorous Research
• Master Outlier Detection Methods: A Comprehensive Guide